Natriuretic peptides in the prognosis and management of acute coronary syndromes

James A de Lemos, W. Frank Peacock, Peter A. McCullough

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Over the past decade, an evidence base has accumulated to support natriuretic peptide (NP) testing for diagnosis, risk assessment, and therapeutic monitoring and guidance of patients with heart failure. Investigators have also explored multiple other potential uses for these tests, including risk assessment of patients with suspected acute coronary syndromes (ACS). This article discusses the utility of NPs in the diagnosis and management of patients with ACS.

Original languageEnglish (US)
Pages (from-to)S24-S34
JournalReviews in Cardiovascular Medicine
Issue numberSUPPL. 2
StatePublished - Mar 2010


  • Acute coronary syndromes
  • Management strategies
  • Natriuretic peptides
  • Risk assessment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Natriuretic peptides in the prognosis and management of acute coronary syndromes'. Together they form a unique fingerprint.

Cite this